Blinatumomab for paediatric mixed phenotype acute leukaemia

Saved in:
Bibliographic Details
Published in:British journal of haematology 2021-10, Vol.195 (2), p.289-292
Main Authors: Bartram, Jack, Balasch‐Carulla, Milena, Bhojaraja, Shashank, Adams, Stuart, Cheng, Danny, Inglott, Sarah, Kulkarni, Nimish, Mahendrayogam, Arunthethy, O’Connor, Olya, Pavasovic, Vesna, Vora, Ajay
Format: Article
Language:English
Subjects:
Aged
Antibodies, Bispecific - administration & dosage
Antibodies, Bispecific - pharmacology
Antibodies, Bispecific - therapeutic use
Antigens, CD19 - drug effects
Antigens, CD19 - genetics
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Combined Modality Therapy - methods
Female
Hematology
Hematopoietic Stem Cell Transplantation - methods
Histone-Lysine N-Methyltransferase - drug effects
Histone-Lysine N-Methyltransferase - genetics
Humans
immunotherapy
Infant
leukaemia
leukaemia therapy
Leukemia
Leukemia, Biphenotypic, Acute - drug therapy
Leukemia, Biphenotypic, Acute - genetics
Leukemia, Biphenotypic, Acute - pathology
Male
mixed phenotype acute leukaemia
Myeloid-Lymphoid Leukemia Protein - drug effects
Myeloid-Lymphoid Leukemia Protein - genetics
Neoplasm, Residual - drug therapy
Neoplasm, Residual - genetics
Neoplasm, Residual - pathology
paediatric haematology
Phenotypes
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Progression-Free Survival
Remission Induction
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.17707